Evidence map›Paper›PMID 40783996›Full record

ArticleJoint diseases and related surgery2025

Evaluation of delayed diagnosis of osteoid osteoma in adolescents and young patients with hip pain.

Ferit Tufan Özgezmez, Gül Öznur Karabıçak, Emre Çullu

Abstract read
In one paragraph

Article in Joint diseases and related surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ferit Tufan Özgezmez
Gül Öznur KarabıçakAdnan Menderes Üniversitesi Tıp Fakültesi Fizyoterapi ve Rehabilitasyon Anabilim Dalı, 09200 Aydın, Türkiye. guloznur@gmail.com.
Emre Çullu

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study aims to evaluate delayed diagnosis of osteoid osteoma (OO) in pediatric patients with hip pain and to identify the diagnostic challenges and errors encountered during this period. PATIENTS AND

methodsBetween May 2010 and July 2022, a total of 18 patients (11 males; 7 females; median age: 12 years; range, 6 to 20 years) with a confirmed diagnosis of OO were retrospectively analyzed. Demographic, clinical, and radiographic data were recorded. The time from symptom onset to diagnosis was calculated for each patient. The date of radiological diagnosis was accepted as the time of diagnosis.

resultsThe median time from symptom onset to diagnosis was 12 months. Right-sided involvement was observed in 61.1% of cases. The most common lesion location was the femoral neck (61.1%), and 66.7% of cases had intra-articular lesions. A limping gait was observed in 61.1% of patients. Additionally, 33.3% of cases reported atrophy of the thigh muscles and/or lower extremities. Night pain was present in 83.3% of cases. A total of 72.2% of cases had a diagnostic delay exceeding six months. Half (50%) of the patients required more than five visits to healthcare providers before receiving an accurate diagnosis.

conclusionThe diagnostic delays for OO located in the hip region can be seen in among children and young adults, primarily due to misdiagnosis and reliance on inconclusive initial imaging findings. To minimize such delays, clinicians should maintain a high index of suspicion, particularly in patients with persistent, unexplained hip pain, and consider imaging studies. Pain lasting over three weeks warrants further diagnostic evaluation in this patient group.

Indexed as

ArthralgiaBone NeoplasmsDelayed DiagnosisHip JointOsteoma, OsteoidAdolescentChildFemaleHumansMaleRetrospective StudiesTime FactorsYoung Adult

Identifiers

PMID40783996
PMCPMC12456355

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.